RIAZZINO (LOCARNO), SWITZERLAND – Linnea, a leading manufacturer and distributor of high quality botanical extracts for the dietary supplement, pharmaceutical and cosmetics industries, is already complying with the FDA requirements of registration that the agency devised to address the potential threat to the domestic and imported food supply, it was announced by Don Stanek, Linnea’s Director of Sales in the USA.
Although the new law takes effect on this December 12, some 90% of foreign and domestic facilities have yet to register with the FDA.
According to the rules, adopted by the FDA following the enactment of the Public Health Security and Bioterrorism Prevention and Response Act, all facilities that manufacture, process, pack or hold food for consumption in the United States must be registered with the FDA. In addition, food importers must give the FDA at least eight hours notice before shipments arrive by sea, four hours notice if by air or mail, and two hours notice if shipments arrive by land.
Since dietary supplements are defined as foods in the U.S., the requirements also apply to manufacturers, processors, packers and holders of dietary supplements and their ingredients.
A major supplier to some of the natural health industry’s main manufacturers, Linnea product range includes Bilberry Extract; Echinacea Angustifolia 4%; Ginkgo biloba Extract EPG 246, Horse Chestnut Fruit Dried Extract, L-5 Hydroxytryptothan; Red Clover Extract IFL 40; Silymarin 80, Valerian; Root 0.8% and Vinpocetine;
Linnea’s high quality extracts and phyto-chemicals are used worldwide in pharmaceutical, dietary supplements and cosmetics. All products are manufactured under full pharmaceutical GMP operating standards. For more information, visit www.linnea-worldwide.com or e-mail [email protected].
# # #